Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 53636-65-0 | MDL No. : | MFCD05662425 |
Formula : | C8H7NO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | JPIJMXOJEHMTPU-UHFFFAOYSA-N |
M.W : | 181.15 | Pubchem ID : | 14425308 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 43.12 |
TPSA : | 87.49 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.98 cm/s |
Log Po/w (iLOGP) : | 0.47 |
Log Po/w (XLOGP3) : | 0.6 |
Log Po/w (WLOGP) : | 0.79 |
Log Po/w (MLOGP) : | -1.13 |
Log Po/w (SILICOS-IT) : | 0.58 |
Consensus Log Po/w : | 0.26 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.55 |
Solubility : | 5.1 mg/ml ; 0.0281 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.01 |
Solubility : | 1.77 mg/ml ; 0.00975 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -1.16 |
Solubility : | 12.6 mg/ml ; 0.0693 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.68 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58.6% | With formic acid; nitric acid In dichloromethane | A) A solution of 3-methyl-8-hydroxyquinoline (15.9 g, 0.10 mole) in methylene chloride is added to 70percent nitric acid (126 g, 1.8 mole) at a temperature of 80°-100° C. over a 1 hour period with stirring. The resulting overhead gases are scrubbed and vented. The reaction mixture is heated at 100°-105° for 4 hours, cooled to 85° C., treated with 88percent formic acid at 85°-95° C. over a 20 minute period, further heated at 85°-95° C. for 0.5 hour, cooled to 0°, stirred for 1 hour and filtered. The filtercake is washed with acetone and dried to give 5-methyl-2,3-pyridinedicarboxylic acid, 10.6 g (58.6percent yield), 97.4percent pure by HPLC analysis. |
[ 98555-51-2 ]
5-Bromopyridine-2,3-dicarboxylic acid
Similarity: 0.86
[ 24195-03-7 ]
4-(Methoxycarbonyl)picolinic acid
Similarity: 0.80
[ 39977-41-8 ]
5-(Hydroxymethyl)picolinic acid
Similarity: 0.80
[ 17874-79-2 ]
5-(Methoxycarbonyl)picolinic acid
Similarity: 0.78
[ 112110-16-4 ]
Dimethyl 5-methylpyridine-2,3-dicarboxylate
Similarity: 0.91
[ 605-38-9 ]
Dimethyl pyridine-2,3-dicarboxylate
Similarity: 0.88
[ 98555-51-2 ]
5-Bromopyridine-2,3-dicarboxylic acid
Similarity: 0.86